Ovarian Cancer Patient Recruitment in Minnesota

TheraNovex connects clinical trial sponsors with pre-screened, eligible Ovarian Cancer patients across Minnesota, including Minneapolis, Saint Paul, Rochester, and beyond.

Ovarian cancer clinical trial recruitment for BRCA-mutant, platinum-sensitive, and platinum-resistant studies.

Who qualifies: Women with epithelial ovarian cancer, including BRCA1/2 mutation carriers and platinum-sensitive/resistant patients.

Recruitment challenges: BRCA testing requirements and prior platinum therapy eligibility criteria.

Our approach: Gynecologic oncology referral networks and ovarian cancer patient advocacy partnerships.

Our recruitment network spans all major metropolitan areas in Minnesota, ensuring broad geographic coverage for your Ovarian Cancer trial.